tiprankstipranks
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market
ATXI
Avenue Therapeutics
RESEARCH TOOLSreports

Avenue Therapeutics (ATXI) Income Statement

331 Followers

Avenue Therapeutics Income Statement

Last quarter (Q4 2025), Avenue Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Avenue Therapeutics's net income was $-709.00K. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.40M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.69M$ 11.28M$ 14.54M$ 8.04M$ 3.74M
Depreciation and Amortization
$ 0.00$ 0.00$ 14.54M$ 0.00$ 3.74M
EBITDA
$ -3.29M$ -11.70M$ 4.05M$ -2.44M$ 7.00K
Operating Income
$ -3.29M$ -11.28M$ -14.54M$ -8.04M$ -3.74M
Other Income/Expenses
$ 339.00K$ -413.00K$ 4.05M$ 4.44M$ 7.00K
Pretax Income
$ -2.95M$ -11.70M$ -10.49M$ -3.60M$ -3.73M
Net Income
$ -2.91M$ -11.65M$ -10.38M$ -3.55M$ -3.73M
Per Share Metrics
Basic EPS
$ -0.93$ -0.90$ -73.60$ -121.91$ -3.29
Diluted EPS
$ -0.93$ -0.90$ -73.48$ -121.91$ -3.29
Weighted Average Shares Outstanding
 3.13M 12.95M 141.00K 29.14K 1.13M
Weighted Average Shares Outstanding (Diluted)
 3.13M 12.95M 141.22K 29.14K 1.13M
Currency in USD

Avenue Therapeutics Earnings and Revenue History